Genmab A/S (FRA:GE91)
24.20
-0.20 (-0.82%)
Last updated: Feb 20, 2026, 8:02 AM CET
Genmab Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,715 | 1,380 | 2,204 | 1,421 | 1,370 |
Short-Term Investments | - | 1,574 | 1,967 | 1,786 | 1,588 |
Cash & Short-Term Investments | 1,715 | 2,954 | 4,171 | 3,207 | 2,958 |
Cash Growth | -41.94% | -29.18% | 30.04% | 8.44% | 11.94% |
Accounts Receivable | 1,112 | 923 | 733 | 820.69 | 515 |
Other Receivables | 40 | 14 | - | 26.15 | 4.74 |
Receivables | 1,152 | 937 | 733 | 846.84 | 519.75 |
Inventory | 18 | 9 | 8 | - | - |
Total Current Assets | 2,885 | 3,900 | 4,912 | 4,054 | 3,478 |
Property, Plant & Equipment | 280 | 265 | 244 | 189.94 | 149.13 |
Long-Term Investments | 37 | 32 | 20 | 19.11 | 56.75 |
Goodwill | 355 | 355 | - | - | - |
Other Intangible Assets | 9,123 | 1,728 | 15 | 20.98 | 38.85 |
Long-Term Accounts Receivable | 22 | 7 | 10 | 6.9 | 4.13 |
Long-Term Deferred Tax Assets | 171 | 127 | 31 | 36.21 | 40.38 |
Total Assets | 12,873 | 6,414 | 5,232 | 4,327 | 3,767 |
Accounts Payable | - | - | - | - | 53.53 |
Accrued Expenses | - | - | - | - | 45.28 |
Current Portion of Long-Term Debt | 273 | - | - | - | - |
Current Portion of Leases | 18 | 13 | 13 | 10.63 | 9.48 |
Current Income Taxes Payable | 43 | 239 | 8 | - | - |
Current Unearned Revenue | 24 | 3 | 5 | 4.74 | 3.98 |
Other Current Liabilities | 1,069 | 489 | 342 | 246.55 | 127.57 |
Total Current Liabilities | 1,427 | 744 | 368 | 261.93 | 239.84 |
Long-Term Debt | 5,001 | - | - | - | - |
Long-Term Leases | 134 | 131 | 101 | 75.14 | 55.52 |
Long-Term Unearned Revenue | 95 | 67 | 71 | 68.97 | 74.49 |
Long-Term Deferred Tax Liabilities | 364 | 330 | - | - | - |
Other Long-Term Liabilities | 5 | 5 | 5 | 1.58 | 1.99 |
Total Liabilities | 7,026 | 1,277 | 545 | 407.62 | 371.84 |
Common Stock | 10 | 10 | 10 | 9.48 | 10.1 |
Additional Paid-In Capital | 1,920 | 1,961 | 1,942 | 1,769 | 1,840 |
Retained Earnings | 4,098 | 3,392 | 2,737 | 2,128 | 1,533 |
Comprehensive Income & Other | -181 | -226 | -2 | 14.08 | 12.39 |
Shareholders' Equity | 5,847 | 5,137 | 4,687 | 3,920 | 3,395 |
Total Liabilities & Equity | 12,873 | 6,414 | 5,232 | 4,327 | 3,767 |
Total Debt | 5,426 | 144 | 114 | 85.78 | 65.01 |
Net Cash (Debt) | -3,711 | 2,810 | 4,057 | 3,122 | 2,893 |
Net Cash Growth | - | -30.74% | 29.96% | 7.91% | 11.69% |
Net Cash Per Share | -59.19 | 43.46 | 61.57 | 47.29 | 43.80 |
Filing Date Shares Outstanding | 61.62 | 63.54 | 65.33 | 65.37 | 65.43 |
Total Common Shares Outstanding | 61.62 | 63.54 | 65.33 | 65.37 | 65.43 |
Working Capital | 1,458 | 3,156 | 4,544 | 3,792 | 3,238 |
Book Value Per Share | 94.89 | 80.85 | 71.74 | 59.96 | 51.89 |
Tangible Book Value | -3,631 | 3,054 | 4,672 | 3,899 | 3,356 |
Tangible Book Value Per Share | -58.93 | 48.06 | 71.51 | 59.64 | 51.29 |
Machinery | 175 | 139 | 135 | 93.25 | 82.14 |
Construction In Progress | 3 | 14 | 6 | 33.48 | 7.95 |
Leasehold Improvements | 132 | 101 | 101 | 59.2 | 61.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.